Design, synthesis and SAR of a novel series of heterocyclic phenylpropanoic acids as GPR120 agonists.
A novel series of 5-membered heterocycle-containing phenylpropanoic acid derivatives was discovered as potent GPR120 agonists with low clearance, high oral bioavailability and in vivo antidiabetic activity in rodents.